Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation

Remi A. Nout; Tjalling Bosse; Carien L. Creutzberg; Ina M. Jurgenliemk-Schulz; Jan J. Jobsen; Ludy C. H. W. Lutgens; Elzbieta M. van der Steen-Banasik; Ronald van Eijk; Natalja T. ter Haar; Vincent T. H. B. M. Smit

doi:10.1016/j.ygyno.2012.05.012

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation

Remi A. Nout, Tjalling Bosse, Carien L. Creutzberg, Ina M. Jurgenliemk-Schulz, Jan J. Jobsen, Ludy C. H. W. Lutgens, Elzbieta M. van der Steen-Banasik, Ronald van Eijk, Natalja T. ter Haar, Vincent T. H. B. M. Smit

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	466-473
Journal	Gynecologic Oncology
Volume	126
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2012.05.012
Publication status	Published - Sep 2012

Keywords

Endometrial cancer
Oncogenic pathway alterations
PI3K-AKT pathway
Wnt signaling pathway
Microsatellite-instability
P53 mutation

Access to Document

10.1016/j.ygyno.2012.05.012

Cite this

Nout, R. A., Bosse, T., Creutzberg, C. L., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., van Eijk, R., ter Haar, N. T., & Smit, V. T. H. B. M. (2012). Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. Gynecologic Oncology, 126(3), 466-473. https://doi.org/10.1016/j.ygyno.2012.05.012

Nout, Remi A. ; Bosse, Tjalling ; Creutzberg, Carien L. ; Jurgenliemk-Schulz, Ina M. ; Jobsen, Jan J. ; Lutgens, Ludy C. H. W. ; van der Steen-Banasik, Elzbieta M. ; van Eijk, Ronald ; ter Haar, Natalja T. ; Smit, Vincent T. H. B. M. / Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. In: Gynecologic Oncology. 2012 ; Vol. 126, No. 3. pp. 466-473.

@article{9e760e30fdb2407ab3f4acccbd1c0145,

title = "Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation",

keywords = "Endometrial cancer, Oncogenic pathway alterations, PI3K-AKT pathway, Wnt signaling pathway, Microsatellite-instability, P53 mutation",

author = "Nout, {Remi A.} and Tjalling Bosse and Creutzberg, {Carien L.} and Jurgenliemk-Schulz, {Ina M.} and Jobsen, {Jan J.} and Lutgens, {Ludy C. H. W.} and {van der Steen-Banasik}, {Elzbieta M.} and {van Eijk}, Ronald and {ter Haar}, {Natalja T.} and Smit, {Vincent T. H. B. M.}",

year = "2012",

month = sep,

doi = "10.1016/j.ygyno.2012.05.012",

language = "English",

volume = "126",

pages = "466--473",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Elsevier Science",

number = "3",

}

Nout, RA, Bosse, T, Creutzberg, CL, Jurgenliemk-Schulz, IM, Jobsen, JJ, Lutgens, LCHW, van der Steen-Banasik, EM, van Eijk, R, ter Haar, NT & Smit, VTHBM 2012, 'Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation', Gynecologic Oncology, vol. 126, no. 3, pp. 466-473. https://doi.org/10.1016/j.ygyno.2012.05.012

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. / Nout, Remi A.; Bosse, Tjalling; Creutzberg, Carien L.; Jurgenliemk-Schulz, Ina M.; Jobsen, Jan J.; Lutgens, Ludy C. H. W.; van der Steen-Banasik, Elzbieta M.; van Eijk, Ronald; ter Haar, Natalja T.; Smit, Vincent T. H. B. M.

In: Gynecologic Oncology, Vol. 126, No. 3, 09.2012, p. 466-473.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation

AU - Nout, Remi A.

AU - Bosse, Tjalling

AU - Creutzberg, Carien L.

AU - Jurgenliemk-Schulz, Ina M.

AU - Jobsen, Jan J.

AU - Lutgens, Ludy C. H. W.

AU - van der Steen-Banasik, Elzbieta M.

AU - van Eijk, Ronald

AU - ter Haar, Natalja T.

AU - Smit, Vincent T. H. B. M.

PY - 2012/9

Y1 - 2012/9

KW - Endometrial cancer

KW - Oncogenic pathway alterations

KW - PI3K-AKT pathway

KW - Wnt signaling pathway

KW - Microsatellite-instability

KW - P53 mutation

U2 - 10.1016/j.ygyno.2012.05.012

DO - 10.1016/j.ygyno.2012.05.012

M3 - Article

VL - 126

SP - 466

EP - 473

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -